"Interleukin-7" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cytokine produced by bone marrow stromal cells that promotes the growth of B-LYMPHOCYTE precursors and is co-mitogenic with INTERLEUKIN-2 for mature T-LYMPHOCYTE activation.
| Descriptor ID |
D015851
|
| MeSH Number(s) |
D12.644.276.374.465.246 D12.776.467.374.465.224 D23.529.374.465.246
|
| Concept/Terms |
Interleukin-7- Interleukin-7
- Interleukin 7
- IL7
- Lymphopoietin-1
- Lymphopoietin 1
- IL-7
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-7".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-7".
This graph shows the total number of publications written about "Interleukin-7" by people in this website by year, and whether "Interleukin-7" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1997 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 3 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 2 | 3 |
| 2009 | 3 | 2 | 5 |
| 2010 | 0 | 2 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 1 | 3 |
| 2020 | 0 | 2 | 2 |
| 2022 | 0 | 4 | 4 |
| 2023 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-7" by people in Profiles.
-
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani. Cytokine. 2024 02; 174:156475.
-
Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells. Int J Mol Sci. 2023 Oct 31; 24(21).
-
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy. Transplant Cell Ther. 2024 Jan; 30(1):71.e1-71.e13.
-
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. Lancet Microbe. 2023 09; 4(9):e692-e703.
-
Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia. Cancer Res Commun. 2022 11; 2(11):1520-1531.
-
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma. Nat Med. 2022 09; 28(9):1872-1882.
-
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia. Br J Haematol. 2022 07; 198(1):137-141.
-
Quantitative restoration of immune defense in old animals determined by naive antigen-specific CD8 T-cell numbers. Aging Cell. 2022 04; 21(4):e13582.
-
IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA-CD62L+CD4+ Invariant NKT Cells With Th-2 Biased Cytokine Production Profile. Front Immunol. 2020; 11:567406.
-
Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. J Clin Invest. 2020 02 03; 130(2):863-876.